Viewing Study NCT02855203


Ignite Creation Date: 2025-12-24 @ 7:24 PM
Ignite Modification Date: 2026-02-22 @ 4:13 AM
Study NCT ID: NCT02855203
Status: COMPLETED
Last Update Posted: 2023-08-03
First Post: 2016-07-28
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Stereotactic Radiotherapy and Anti-PD1 Antibody (Pembrolizumab) for Oligometastatic Renal Tumours
Sponsor:
Organization: